Literature DB >> 32023448

CD45RB Status of CD8+ T Cell Memory Defines T Cell Receptor Affinity and Persistence.

Scott M Krummey1, Anna B Morris2, Jesica R Jacobs3, Donald J McGuire4, Satomi Ando4, Katherine P Tong2, Weiwen Zhang2, Jennifer Robertson2, Sara A Guasch2, Koichi Araki4, Christian P Larsen2, Brian D Evavold3, Haydn T Kissick5, Mandy L Ford2.   

Abstract

The identity of CD45 isoforms on the T cell surface changes following the activation of naive T cells and impacts intracellular signaling. In this study, we find that the anti-viral memory CD8+ T pool is unexpectedly comprised of both CD45RBhi and CD45RBlo populations. Relative to CD45RBlo memory T cells, CD45RBhi memory T cells have lower affinity and display greater clonal diversity, as well as a persistent CD27hi phenotype. The CD45RBhi memory population displays a homeostatic survival advantage in vivo relative to CD45RBlo memory, and long-lived high-affinity cells that persisted long term convert from CD45RBlo to CD45RBhi. Human CD45RO+ memory is comprised of both CD45RBhi and CD45RBlo populations with distinct phenotypes, and antigen-specific memory to two viruses is predominantly CD45RBhi. These data demonstrate that CD45RB status is distinct from the conventional central/effector T cell memory classification and has potential utility for monitoring and characterizing pathogen-specific CD8+ T cell responses.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD45; T cell memory; TCR affinity

Year:  2020        PMID: 32023448      PMCID: PMC7155808          DOI: 10.1016/j.celrep.2020.01.016

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  48 in total

1.  CD27 is required for generation and long-term maintenance of T cell immunity.

Authors:  J Hendriks; L A Gravestein; K Tesselaar; R A van Lier; T N Schumacher; J Borst
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

Review 2.  CD45: a critical regulator of signaling thresholds in immune cells.

Authors:  Michelle L Hermiston; Zheng Xu; Arthur Weiss
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

3.  Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms.

Authors:  Zheng Xu; Arthur Weiss
Journal:  Nat Immunol       Date:  2002-07-22       Impact factor: 25.606

Review 4.  Consequences of regulated pre-mRNA splicing in the immune system.

Authors:  Kristen W Lynch
Journal:  Nat Rev Immunol       Date:  2004-12       Impact factor: 53.106

Review 5.  MYC and HIF in shaping immune response and immune metabolism.

Authors:  J N Rashida Gnanaprakasam; John William Sherman; Ruoning Wang
Journal:  Cytokine Growth Factor Rev       Date:  2017-03-23       Impact factor: 7.638

6.  Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.

Authors:  Jason M Brenchley; Nitin J Karandikar; Michael R Betts; David R Ambrozak; Brenna J Hill; Laura E Crotty; Joseph P Casazza; Janaki Kuruppu; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

Review 7.  CD8+ T cell efficacy in vaccination and disease.

Authors:  Victor Appay; Daniel C Douek; David A Price
Journal:  Nat Med       Date:  2008-06       Impact factor: 53.440

8.  Lifespan of human lymphocyte subsets defined by CD45 isoforms.

Authors:  C A Michie; A McLean; C Alcock; P C Beverley
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

9.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Authors:  Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

10.  The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression.

Authors:  Pratip K Chattopadhyay; Michael R Betts; David A Price; Emma Gostick; Helen Horton; Mario Roederer; Stephen C De Rosa
Journal:  J Leukoc Biol       Date:  2008-10-10       Impact factor: 4.962

View more
  5 in total

1.  A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity.

Authors:  Miriam Y Kim; Reyka Jayasinghe; Jessica M Devenport; Julie K Ritchey; Michael P Rettig; Julie O'Neal; Karl W Staser; Krista M Kennerly; Alun J Carter; Feng Gao; Byung Ha Lee; Matthew L Cooper; John F DiPersio
Journal:  Nat Commun       Date:  2022-06-13       Impact factor: 17.694

2.  CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients.

Authors:  Mingming Jin; Nannan Shi; Meng Wang; Chunzi Shi; Shengjie Lu; Qing Chang; Shuang Sha; Yun Lin; Yingmin Chen; Hui Zhou; Kaiyi Liang; Xuyuan Huang; Yuxin Shi; Gang Huang
Journal:  Aging (Albany NY)       Date:  2020-10-16       Impact factor: 5.682

Review 3.  P2X7 Receptor at the Crossroads of T Cell Fate.

Authors:  Elizabeth Rivas-Yáñez; Carlos Barrera-Avalos; Brian Parra-Tello; Pedro Briceño; Mariana V Rosemblatt; Juan Saavedra-Almarza; Mario Rosemblatt; Claudio Acuña-Castillo; María Rosa Bono; Daniela Sauma
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

4.  IL4I1 Accelerates the Expansion of Effector CD8+ T Cells at the Expense of Memory Precursors by Increasing the Threshold of T-Cell Activation.

Authors:  Marie-Line Puiffe; Aurélie Dupont; Nouhoum Sako; Jérôme Gatineau; José L Cohen; Denis Mestivier; Agnès Lebon; Armelle Prévost-Blondel; Flavia Castellano; Valérie Molinier-Frenkel
Journal:  Front Immunol       Date:  2020-12-04       Impact factor: 7.561

Review 5.  Relationship of 2D Affinity to T Cell Functional Outcomes.

Authors:  Elizabeth M Kolawole; Tracey J Lamb; Brian D Evavold
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.